文献速递复苏、休克与脓毒症

院外心脏骤停期间的鉴别诊断与病因特异性治疗:一项回顾性描述性研究

Differential diagnosis and cause-specific treatment during out-of-hospital cardiac arrest: a retrospective descriptive study.
PubMed 文献 · Scand J Trauma Resusc Emerg Med · 2023-04-11
一句话结论在医师配备的HEMS单元中,84%的院外心脏骤停病例使用了超声或血样分析,15%接受了病因特异性治疗。

该回顾性描述性研究基于医师配备的直升机紧急医疗服务(HEMS)单元,纳入2016至2019年间HEMS单元到达时正在进行CPR的549例非创伤性院外心脏骤停(OHCA)患者。研究记录了CPR期间超声检查、血样分析及病因特异性治疗(胸外按压、气道管理、通气、除颤、肾上腺素或胺碘酮以外的操作或药物)的频率。结果显示超声用于331例(60%),血样分析用于136例(24%),85例(15%)接受了病因特异性治疗,最常见为转运至体外CPR和经皮冠状动脉介入治疗(PCI)(n=30)、溶栓(n=23)、碳酸氢钠(n=17)、葡萄糖酸钙(n=11)和液体复苏(n=10)。作者认为,HEMS医师在84%的OHCA病例中使用了超声或血样分析,病因特异性治疗使用相对不频繁,鉴别诊断流程对更有效病因特异性治疗的影响有待评估。

要点

  • 549例非创伤性OHCA患者中,CPR期间超声使用331例(60%),血样分析使用136例(24%),合计84%的病例使用了至少一种鉴别诊断工具。
  • 85例(15%)接受了病因特异性治疗,最常见为转运至体外CPR和PCI(n=30),其次为溶栓(n=23)、碳酸氢钠(n=17)。
  • 其他病因特异性治疗包括葡萄糖酸钙(n=11)和液体复苏(n=10)。
  • 作者认为,OHCA期间鉴别诊断工具使用频繁,而病因特异性治疗使用相对不频繁。
  • 作者提出,应评估鉴别诊断流程对OHCA期间更有效病因特异性治疗的影响。

适用人群与场景

  • 2016至2019年间,医师配备的直升机紧急医疗服务(HEMS)单元到达时正在进行CPR的非创伤性OHCA患者,共549例。

处置流程与药物剂量

  • CPR期间进行的病因特异性治疗包括:转运至体外CPR和经皮冠状动脉介入治疗(PCI)(n=30)、溶栓(n=23)、碳酸氢钠(n=17)、葡萄糖酸钙(n=11)、液体复苏(n=10)。

研究设计与关键结果

  • 研究类型为回顾性描述性研究,在医师配备的HEMS单元进行,纳入549例非创伤性OHCA患者。
  • CPR期间超声检查用于331例(60%),血样分析用于136例(24%)。
  • 85例(15%)接受了病因特异性治疗,最常见为转运至体外CPR和PCI(n=30),其次为溶栓(n=23)、碳酸氢钠(n=17)、葡萄糖酸钙(n=11)、液体复苏(n=10)。

证据类型、等级与局限

  • 证据类型:回顾性描述性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,应评估鉴别诊断流程对OHCA期间更有效病因特异性治疗的影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The cardiopulmonary resuscitation (CPR) guidelines recommend identifying and correcting the underlying reversible causes of out-of-hospital cardiac arrest (OHCA). However, it is uncertain how often these causes can be identified and treated. Our aim was to estimate the frequency of point of care ultrasound examinations, blood sample analyses and cause-specific treatments during OHCA.

METHODS: We performed a retrospective study in a physician-staffed helicopter emergency medical service (HEMS) unit. Data on 549 non-traumatic OHCA patients who were undergoing CPR at the arrival of the HEMS unit from 2016 to 2019 were collected from the HEMS database and patient records. We also recorded the frequency of ultrasound examinations, blood sample analyses and specific therapies provided during OHCA, such as procedures or medications other than chest compressions, airway management, ventilation, defibrillation, adrenaline or amiodarone.

RESULTS: Of the 549 patients, ultrasound was used in 331 (60%) and blood sample analyses in 136 (24%) patients during CPR. A total of 85 (15%) patients received cause-specific treatment, the most common ones being transportation to extracorporeal CPR and percutaneous coronary intervention (PCI) (n = 30), thrombolysis (n = 23), sodium bicarbonate (n = 17), calcium gluconate administration (n = 11) and fluid resuscitation (n = 10).

CONCLUSION: In our study, HEMS physicians deployed ultrasound or blood sample analyses in 84% of the encountered OHCA cases. Cause-specific treatment was administered in 15% of the cases. Our study demonstrates the frequent use of differential diagnostic tools and relatively infrequent use of cause-specific treatment during OHCA. Effect on protocol for differential diagnostics should be evaluated for more efficient cause specific treatment during OHCA.

来源:Scand J Trauma Resusc Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Heikkilä E, Jousi M, Nurmi J, et al. Differential diagnosis and cause-specific treatment during out-of-hospital cardiac arrest: a retrospective descriptive study. Scand J Trauma Resusc Emerg Med. 2023. PMID: 37041592. doi:10.1186/s13049-023-01080-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。